Table 1.
The Lifescore Study | |||
---|---|---|---|
N |
Cases 57 |
Controls 171 |
P-value |
Age, years ± SD | 72.3 ± 10.3 | 72.2 ± 9.9 | 0.93 |
Female n (%) | 15 (26.3%) | 45 (26.3%) | 0.99 |
Diabetes n (%) | 11 (19.6%) | 3 (1.83%) | 0.01 |
Hypertension n (%) | 29 (50.9%) | 76 (44.4%) | 0.4 |
Total Cholesterol, mg/dL ± SD | 195 ± 42 | 209 ± 151 | 0.51 |
HDL, mg/dL ± SD | 50 ± 20 | 53 ± 18 | 0.35 |
Cholesterol medication use n (%) | 15 (26.3%) | 24 (14.0%) | 0.03 |
BMI (kg/m2) ± SD | 26.6 ± 4.2 | 26.5 ± 3.9 | 0.79 |
Smoking status | 0.11 | ||
Never | 23 (40.3%) | 88 (51.5%) | |
Former | 28 (49.1%) | 76 (44.4%) | |
Current | 6 (10.5%) | 7 (4.1%) | |
Agatston CAC Score, Median (IQR) | 315 (101, 1024) | 202 (5, 794) | 0.05 |
Ordinal Score, Median (IQR) | 3 (2, 4) | 2 (1, 3) | 0.01 |
IQR = interquartile range